bevacizumab (Q413299)

From Wikidata
Jump to navigation Jump to search
pharmaceutical drug
  • 12-IGG1
  • RG-435
  • antiVEGF
  • R-435
  • Rhumab-VEGF
  • Avastin
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    bevacizumab
    pharmaceutical drug
    • 12-IGG1
    • RG-435
    • antiVEGF
    • R-435
    • Rhumab-VEGF
    • Avastin

    Statements

    mass
    149,000 dalton
    1 reference
    stated in
    DrugBank
    DrugBank ID
    DB00112
    chemical formula
    C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄
    0 references
    medical condition treated
    Commons category
    Bevacizumab
    0 references

    Identifiers

    HSDB ID
    8080
    1 reference
    stated in
    Hazardous Substances Data Bank
    HSDB ID
    8080
    publication date
    28 October 2019
    title
    Bevacizumab (English)
    retrieved
    10 May 2021
    DrugBank ID
    DB00112
    0 references
    CA PROP 65 ID
    bevacizumab
    0 references
    DeCS ID
    55974
    0 references
    electronic Essential Medicines List medicine ID
    238
    1 reference
    reference URL
    https://list.essentialmeds.org/medicines/238
    title
    eEML - Electronic Essential Medicines List (English)
    retrieved
    23 October 2021
    Microsoft Academic ID
    2777802072
    0 references
    2910640057
    0 references
    YSO ID
    39032
    subject named as
    bevasitsumabi
    bevacizumab
    1 reference
    stated in
    YSO-Wikidata mapping project
    retrieved
    28 January 2022
     
    edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                  Retrieved from "https://www.wikidata.org/w/index.php?title=Q413299&oldid=2294981668"